Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
PTC Therapeutics
AddedFeb 19, 2024
UpdatedJun 28, 2026
PTC Therapeutics

PTC Therapeutics

Public

PTC Therapeutics, Inc.: A US-based pharmaceutical company specializing in oral, small-molecule drugs for genetic disorders, oncology, and infectious diseases.

HQ
South Plainfield, NJ, US
Founded
1998
Overview
Compare
Fundraising
Employees
Website

Founded in 1998, PTC Therapeutics, Inc. is a US-based pharmaceutical company dedicated to developing orally administered, small-molecule drugs targeting genetic disorders, oncology, and infectious diseases. The company's core mission is to discover and commercialize innovative treatments that address unmet medical needs, improving the quality of life for patients worldwide. PTC Therapeutics focuses on creating therapies that are both effective and accessible, aiming to transform the landscape of rare disease treatment.

Notable figures affiliated with PTC Therapeutics include Stuart W. Peltz, a co-founder and key leader in the company's strategic direction. The company has attracted significant investment from prominent venture capital firms and institutional investors. Key achievements include the development and approval of several groundbreaking therapies, such as Translarna for Duchenne muscular dystrophy. PTC Therapeutics' impact is evident in its contributions to advancing medical science and providing hope to patients with rare and challenging conditions.

PTC Therapeutics - Similar Companies

Amicus Therapeutics logo

Amicus Therapeutics

amicusrx.com

Sarepta Therapeutics logo

Sarepta Therapeutics

sarepta.com

BioCryst Pharmaceuticals logo

BioCryst Pharmaceuticals

biocryst.com

United Therapeutics logo

United Therapeutics

Astria Therapeutics logo

Astria Therapeutics

astriatx.com

Ultragenyx Pharmaceutical logo

Ultragenyx Pharmaceutical

ultragenyx.com

Pliant Therapeutics logo

Pliant Therapeutics

pliantrx.com

Ionis Pharmaceuticals logo

Ionis Pharmaceuticals

ionispharma.com

Theravance Biopharma logo

Theravance Biopharma

theravance.com

Harmony Biosciences logo

Harmony Biosciences

Intercept Pharmaceuticals logo

Intercept Pharmaceuticals

Triplet Therapeutics logo

Triplet Therapeutics

triplettx.com

TG Therapeutics logo

TG Therapeutics

tgtherapeutics.com

SpringWorks Therapeutics logo

SpringWorks Therapeutics

springworkstx.com

Vertex Pharmaceuticals logo

Vertex Pharmaceuticals

vrtx.com

PTC Therapeutics - Quick Facts

Who are PTC Therapeutics' competitors?

Companies similar to PTC Therapeutics include Amicus Therapeutics, Sarepta Therapeutics, BioCryst Pharmaceuticals and United Therapeutics.

When was PTC Therapeutics founded?

PTC Therapeutics was founded in 1998.

Where is PTC Therapeutics' headquarters located?

PTC Therapeutics' headquarters is located in South Plainfield, NJ, US.

When was PTC Therapeutics' last funding round?

PTC Therapeutics' most recent funding round was for $1B (USD) in October 2022.

How much has PTC Therapeutics raised to-date?

As of Oct 27, 2022, PTC Therapeutics has raised a total of $1.6B (USD).

How many employees does PTC Therapeutics have?

PTC Therapeutics has 1,402 employees as of Feb 6, 2024.

PTC Therapeutics - Classification

Industry
  • Hardware
Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Pharmaceuticals
Tags
  • Healthcare
Unique IDs
  • ein: 043416587
  • secCik: 0001070081
  • ticker: PTCT
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 14 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 620000Health Care and Social Assistance
  • 541000Professional, Scientific, and Technical Services
  • 623000Nursing and Residential Care Facilities
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research